Search for: "Teva Pharmaceuticals"
Results 341 - 360
of 1,423
Sort by Relevance
|
Sort by Date
12 Oct 2018, 7:50 am
Teva Pharmaceuticals, blocking patent arguments have arisen in the Federal Circuit primarily in the pharmaceutical patent context, and until now have largely been limited to undermining evidence of commercial success. [read post]
11 Oct 2018, 12:57 am
As mentioned above, this decision came out before the CJEU’s judgment in C121/17 TEVA UK Ltd and others. [read post]
9 Oct 2018, 2:13 pm
Teva Pharmaceuticals (Tuesday, Dec. 4): Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention Gamble v. [read post]
3 Oct 2018, 8:51 am
Teva Pharmacetuicals et al. [read post]
3 Oct 2018, 3:48 am
Teva, which focuses on the meaning of “on sale ” in the Section 102 of the Patent Act as revised by the 2011 America Invents Act. [read post]
29 Sep 2018, 8:09 pm
Teva Parenteral Medicines Inc. -- Vanda Pharmaceuticals Inc. v. [read post]
24 Sep 2018, 1:08 pm
The Supreme Court has agreed to hear the following cases for the upcoming term. [read post]
17 Sep 2018, 6:48 am
(Torrent), Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis), and Torrent Pharmaceuticals Limited. [read post]
11 Sep 2018, 10:00 pm
Teva Pharmaceuticals USA the Supreme Court agreed to answer the question whether secret sales qualify as prior art under the new law. [read post]
10 Sep 2018, 10:17 am
.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
30 Aug 2018, 6:34 am
In a forthcoming article, we tell the story of our class action against Teva Pharmaceutical Industries as an illustration of the global race to laxity in the regulation of capital markets. [read post]
26 Aug 2018, 4:35 am
Teva Pharmaceuticals USA Inc., on appeal from the Federal Circuit. [read post]
26 Aug 2018, 4:35 am
Teva Pharmaceuticals USA Inc., on appeal from the Federal Circuit. [read post]
25 Aug 2018, 9:09 pm
Teva Pharmaceuticals decision holding that the defense of tribal sovereign immunity does not apply to IPR proceedings; • Assessing the latest decisions on § 101 and their implications for branded pharmaceuticals; • Reviewing the state... [read post]
21 Aug 2018, 9:58 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals... [read post]
15 Aug 2018, 9:26 am
Oral Arg. at 20:00–07.Both Teva and an 1859 case were cited:Imposing such arequirement would be inconsistent with the SupremeCourt’s guidance in Teva Pharmaceuticals, where theCourt held that, even in cases in which the district courtfinds a need to look beyond the patent’s intrinsic evidenceand to consult extrinsic evidence, the district court muststill conduct a legal analysis: “whether a skilled artisanwould ascribe that same meaning to that term… [read post]
9 Aug 2018, 9:05 am
The manufacturers, distributors and labels affected by the recall include: Solco Healthcare Teva Pharmaceuticals Industries Inc. [read post]
8 Aug 2018, 1:51 pm
The current Supreme Court is friendly toward big business. [read post]
31 Jul 2018, 7:58 am
Accordingly, it seems reasonable to interpret the Teva v. [read post]
27 Jul 2018, 12:13 pm
Zhejiang Huahai was manufacturing the contaminated valsartan component and selling it to several U.S. pharmaceutical companies including Teva Pharmaceuticals Ltd. and Solco Healthcare. [read post]
